Dr. Robert A. Pickett, M.D.
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Mississippi School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,056
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Mississippi School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
TN license 35890 -
Cardiovascular Disease Physician
TN license 35890
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ascension Saint Thomas Hospital Nashville, TN
- The Medical Center (bowling Green) Bowling Green, KY
- Saint Thomas River PArk Hospital Mcminnville, TN
- Tristar Northcrest Medical Center Springfield, TN
- Saint Thomas Highlands Hospital Sparta, TN
Medical groups
- Saint Thomas Medical PArtners (590 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,056
- Services billed
- 7,169
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 1,811 | 573 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,522 | 226 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 1,413 | 176 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 1,371 | 431 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 501 | 58 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 447 | 144 |
| Established patient office or other outpatient visit, 30-39 minutes | 358 | 328 |
| Programming of dual lead pacemaker system | 321 | 265 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 206 | 194 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 99 | 57 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Nashville, TN | 719 |
| Metoprolol Succinate Other prescribers in Nashville, TN | 652 |
| Flecainide Acetate Other prescribers in Nashville, TN | 377 |
| Xarelto (rivaroxaban) Other prescribers in Nashville, TN | 310 |
| Sotalol (sotalol hcl) Other prescribers in Nashville, TN | 202 |
| Warfarin Sodium Other prescribers in Nashville, TN | 137 |
| Metoprolol Tartrate Other prescribers in Nashville, TN | 136 |
| Amiodarone Hcl Other prescribers in Nashville, TN | 132 |
| Furosemide Other prescribers in Nashville, TN | 100 |
| Dofetilide | 83 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 69 payments worth $21,906 in total to this clinician.
| Boston Scientific Corporation | $21,197 |
|---|---|
| Medtronic, Inc. | $668 |
| Daiichi Sankyo Inc. | $25.10 |
| Pfizer Inc. | $16.00 |
| Compensation for services other than consulting (speaking, faculty) | $10,625 |
|---|---|
| Consulting Fee | $7,188 |
| Food and Beverage | $3,023 |
| Travel and Lodging | $1,071 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Aug 28, 2025 | Consulting Fee WATCHMAN FLX · WATCHMAN FLX_IC | $6,563 |
| Boston Scientific Corporation Jul 16, 2025 | Compensation for services other than consulting (speaking, faculty) General - Therapies · General - Therapies_CRM | $5,000 |
| Boston Scientific Corporation Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) FARAPULSE · FARAPULSE_EP | $5,000 |
| Boston Scientific Corporation Aug 28, 2025 | Consulting Fee WATCHMAN FLX · WATCHMAN FLX_IC | $625 |
| Boston Scientific Corporation Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) FARAPULSE · FARAPULSE_EP | $625 |
| Boston Scientific Corporation Jun 5, 2025 | Travel and Lodging WATCHMAN · WATCHMAN Pro_IC · travel to Minneapolis, MN · in-kind | $247 |
| Boston Scientific Corporation Jun 6, 2025 | Travel and Lodging WATCHMAN · WATCHMAN Pro_IC · travel to Minneapolis, MN · in-kind | $247 |
| Boston Scientific Corporation Jun 6, 2025 | Travel and Lodging WATCHMAN · WATCHMAN Pro_IC · travel to Minneapolis, MN · in-kind | $225 |
| Boston Scientific Corporation Jun 6, 2025 | Travel and Lodging WATCHMAN · WATCHMAN Pro_IC · travel to Minneapolis, MN · in-kind | $214 |
| Boston Scientific Corporation Jun 7, 2025 | Travel and Lodging WATCHMAN · WATCHMAN Pro_IC · travel to Minneapolis, MN · in-kind | $137 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 3 companies. The companies reported $246,865 in research payments for these studies, mostly to the institutions running them.
- SIMPLAAFY Clinical Trial
Boston Scientific Corporation · Active, not recruiting · NCT06521463 - A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fi…
Janssen Research & Development, LLC - ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study
Boston Scientific Corporation · Completed · NCT06526546 - ELEVATE-HFpEF
Medtronic, Inc. - A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation
Boston Scientific Corporation · Completed · NCT05443594 - HEAL-LAA Clinical Trial
Boston Scientific Corporation · Completed · NCT05809596 - LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
Boston Scientific Corporation · Completed · NCT04790344 - Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Boston Scientific Corporation · Completed · NCT03795298 - Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
Boston Scientific Corporation · Terminated · NCT02928497
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.